WEST PHARMACEUTICAL SERVICES, INC. (WST) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 202.90M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 4.08B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $0.00 | $202.90M | (m) | (m) | $4.08B | (m) |
| 2026-03-31 | (m) | (m) | $0.00 | $202.80M | (m) | (m) | $4.11B | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | $202.80M | (m) | (m) | $4.27B | (m) |
| 2025-09-30 | (m) | (m) | $0.00 | $202.70M | (m) | (m) | $4.11B | (m) |
| 2025-06-30 | (m) | (m) | $0.00 | $202.60M | (m) | (m) | $3.95B | (m) |
| 2025-03-31 | (m) | (m) | $0.00 | $202.60M | (m) | (m) | $3.62B | (m) |
| 2024-12-31 | (m) | (m) | $0.00 | $202.60M | (m) | (m) | $3.64B | (m) |
| 2024-09-30 | (m) | (m) | $0.00 | $202.60M | (m) | (m) | $3.68B | (m) |
| 2024-06-30 | (m) | (m) | $132.90M | $72.90M | (m) | (m) | $3.49B | (m) |
| 2024-03-31 | (m) | (m) | $133.40M | $72.80M | (m) | (m) | $3.60B | (m) |
| 2023-12-31 | (m) | (m) | $134.00M | $72.80M | (m) | (m) | $3.83B | (m) |
| 2023-09-30 | (m) | (m) | $55.20M | $152.10M | (m) | (m) | $3.75B | (m) |
| 2023-06-30 | (m) | (m) | $2.20M | $205.60M | (m) | (m) | $3.67B | (m) |
| 2023-03-31 | (m) | (m) | $2.20M | $206.10M | (m) | (m) | $3.72B | (m) |
| 2022-12-31 | (m) | (m) | $2.20M | $206.70M | (m) | (m) | $3.62B | (m) |
| 2022-09-30 | (m) | (m) | $2.20M | $207.20M | (m) | (m) | $3.32B | (m) |
| 2022-06-30 | (m) | (m) | $44.20M | $207.80M | (m) | (m) | $3.36B | (m) |
| 2022-03-31 | (m) | (m) | $44.20M | $208.30M | (m) | (m) | $3.29B | (m) |
| 2021-12-31 | (m) | (m) | $44.20M | $208.80M | (m) | (m) | $3.31B | (m) |
| 2021-09-30 | (m) | (m) | $44.20M | $209.90M | (m) | (m) | $3.14B | (m) |
| 2021-06-30 | (m) | (m) | $2.30M | $251.80M | (m) | (m) | $2.93B | (m) |
| 2021-03-31 | (m) | (m) | $2.30M | $252.30M | (m) | (m) | $2.74B | (m) |
| 2020-12-31 | (m) | (m) | $2.30M | $252.90M | (m) | (m) | $2.79B | (m) |
| 2020-09-30 | (m) | (m) | $2.30M | $253.40M | (m) | (m) | $2.58B | (m) |
| 2020-06-30 | (m) | (m) | $2.30M | $253.90M | (m) | (m) | $2.39B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $254.40M | (m) | (m) | $2.25B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $255.00M | (m) | (m) | $2.34B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $195.10M | (m) | (m) | $2.17B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $196.00M | (m) | (m) | $2.12B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $195.50M | (m) | (m) | $2.04B | (m) |
| 2018-12-31 | (m) | (m) | (m) | $196.00M | (m) | (m) | $1.98B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $196.20M | (m) | (m) | $1.95B | (m) |
| 2018-06-30 | (m) | (m) | (m) | $196.40M | (m) | (m) | $1.87B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $198.00M | (m) | (m) | $1.87B | (m) |
| 2017-12-31 | (m) | (m) | (m) | $197.00M | (m) | (m) | $1.86B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $196.60M | (m) | (m) | $1.93B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $195.70M | (m) | (m) | $1.84B | (m) |
| 2017-03-31 | (m) | (m) | (m) | $194.20M | (m) | (m) | $1.73B | (m) |
| 2016-12-31 | (m) | (m) | (m) | $226.20M | (m) | (m) | $1.72B | (m) |
| 2016-09-30 | (m) | (m) | (m) | $228.60M | (m) | (m) | $1.74B | (m) |
| 2016-06-30 | (m) | (m) | (m) | $228.90M | (m) | (m) | $1.71B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $229.50M | (m) | (m) | $1.67B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $228.90M | (m) | (m) | $1.70B | (m) |
| 2015-09-30 | (m) | (m) | (m) | $231.50M | (m) | (m) | $1.67B | (m) |
| 2015-06-30 | (m) | (m) | (m) | $231.70M | (m) | (m) | $1.66B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $231.90M | (m) | (m) | $1.60B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $309.50M | (m) | (m) | $1.67B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $315.50M | (m) | (m) | $1.67B | (m) |
| 2014-06-30 | (m) | (m) | (m) | $359.30M | (m) | (m) | $1.70B | (m) |
| 2014-03-31 | (m) | (m) | (m) | $390.70M | (m) | (m) | $1.71B | (m) |
| 2013-12-31 | (m) | (m) | (m) | $371.30M | (m) | (m) | $1.67B | (m) |
| 2013-09-30 | (m) | (m) | (m) | $381.10M | (m) | (m) | $1.66B | (m) |
| 2013-06-30 | (m) | (m) | (m) | $394.70M | (m) | (m) | $1.61B | (m) |
| 2013-03-31 | (m) | (m) | (m) | $428.40M | (m) | (m) | $1.58B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $378.80M | (m) | (m) | $1.56B | (m) |
| 2012-09-30 | (m) | (m) | (m) | $362.10M | (m) | (m) | $1.53B | (m) |
| 2012-06-30 | (m) | (m) | (m) | $296.40M | (m) | (m) | $1.46B | (m) |
| 2012-03-31 | (m) | (m) | (m) | $294.90M | (m) | (m) | $1.46B | (m) |
| 2011-12-31 | (m) | (m) | (m) | $299.30M | (m) | (m) | $1.40B | (m) |
| 2011-09-30 | (m) | (m) | (m) | $323.30M | (m) | (m) | $1.40B | (m) |
| 2011-06-30 | (m) | (m) | (m) | $367.20M | (m) | (m) | $1.42B | (m) |
| 2011-03-31 | (m) | (m) | (m) | $364.70M | (m) | (m) | $1.37B | (m) |
| 2010-12-31 | (m) | (m) | (m) | $358.10M | (m) | (m) | $1.29B | (m) |
| 2010-09-30 | (m) | (m) | (m) | $369.30M | (m) | (m) | $1.30B | (m) |
| 2010-06-30 | (m) | (m) | (m) | $356.80M | (m) | (m) | $1.22B | (m) |
| 2009-12-31 | (m) | (m) | (m) | $379.10M | (m) | (m) | $1.27B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |